JP2006501160A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501160A5
JP2006501160A5 JP2004510719A JP2004510719A JP2006501160A5 JP 2006501160 A5 JP2006501160 A5 JP 2006501160A5 JP 2004510719 A JP2004510719 A JP 2004510719A JP 2004510719 A JP2004510719 A JP 2004510719A JP 2006501160 A5 JP2006501160 A5 JP 2006501160A5
Authority
JP
Japan
Prior art keywords
compounds
measured
assembly
effect
amyloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004510719A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501160A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017992 external-priority patent/WO2003103598A2/en
Publication of JP2006501160A publication Critical patent/JP2006501160A/ja
Publication of JP2006501160A5 publication Critical patent/JP2006501160A5/ja
Pending legal-status Critical Current

Links

JP2004510719A 2002-06-07 2003-06-09 アミロイド症を処置するためのアミジン誘導体 Pending JP2006501160A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38700102P 2002-06-07 2002-06-07
PCT/US2003/017992 WO2003103598A2 (en) 2002-06-07 2003-06-09 Amidine derivatives for treating amyloidosis

Publications (2)

Publication Number Publication Date
JP2006501160A JP2006501160A (ja) 2006-01-12
JP2006501160A5 true JP2006501160A5 (enExample) 2006-03-02

Family

ID=29736249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004510719A Pending JP2006501160A (ja) 2002-06-07 2003-06-09 アミロイド症を処置するためのアミジン誘導体

Country Status (6)

Country Link
EP (1) EP1572129A4 (enExample)
JP (1) JP2006501160A (enExample)
AU (1) AU2003251418A1 (enExample)
CA (1) CA2488493A1 (enExample)
NO (1) NO20040497L (enExample)
WO (1) WO2003103598A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070088067A1 (en) * 2003-09-05 2007-04-19 Tidwell Richards R Novel amidine compounds for treating microbial infections
AU2004284091A1 (en) * 2003-10-24 2005-05-06 Georgia State University Research Foundation, Inc Dicationic triaryl analogs as anti-protozoan agents
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
AU2004316081A1 (en) * 2004-01-23 2005-09-01 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
BRPI0608581A2 (pt) * 2005-03-14 2010-01-19 Transtech Pharma Inc derivados de benzazol, composiÇÕes e mÉtodos de uso como inibidores de b-secretase
AU2006201739A1 (en) 2005-05-05 2006-11-23 The University Of North Carolina At Chapel Hill Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
DK2247558T4 (da) * 2008-02-14 2024-07-29 Lilly Co Eli Nye billeddannelsesmidler til detektering af neurologisk dysfunktion
FR2933692B1 (fr) 2008-07-10 2022-12-02 Univ Nancy 1 Henri Poincare Nouveaux composes, leur utilisation comme medicaments, et leur procede de preparation
US8454979B2 (en) 2009-02-20 2013-06-04 Meisho Co., Ltd. Immunopotentiating composition and process for producing same
EP4603484A2 (en) 2019-12-19 2025-08-20 Georgia State University Research Foundation, Inc. Compounds for the treatment of bacterial infections and potentiation of antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635668B1 (en) * 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
WO2003017994A1 (en) * 2001-08-31 2003-03-06 Neurochem (International) Limited Amidine derivatives for treating amyloidosis

Similar Documents

Publication Publication Date Title
JP2006501160A5 (enExample)
JP2002501889A5 (enExample)
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
JP2008533191A5 (enExample)
WO2006055747A3 (en) Bis(thio-hydrazide amides) for increasing hsp70 expression
JP2004506604A5 (enExample)
JP2012505235A5 (enExample)
ATE341557T1 (de) Neue phosphitverbindungen und neue phosphitmetallkomplexe
KR920002603A (ko) 피라졸로 피리딘 화합물 및 그 제조방법
JP2001515010A5 (enExample)
US5776970A (en) Tryptophan derivatives as protein tyrosine kinase blockers and their use in the treatment of neoplastic diseases
NO303121B1 (no) AnalogifremgangsmÕte ved fremstilling av terapeutisk aktive metylenbisfosfonsyreamid- og esteramidderivater
SI9420052B (sl) Kristalni brezvodni mikofenolatni mofetil in njegova intravenozna formulacija
CA2036905A1 (en) Condensed thiazole compounds, their production and use
Kimura et al. Silver-catalyzed asymmetric Michael addition of azomethine ylide to arylidene diphosphonates using ThioClickFerrophos ligand
DE69905131D1 (de) Isochroman Verbindungen und Verfahren zu deren Produktion
JP2012531443A5 (enExample)
He et al. Rhenium analogues of promising renal imaging agents with a {99mTc (CO) 3}+ core bound to cysteine-derived dipeptides, including lanthionine
JP2008502673A5 (enExample)
JP4162927B2 (ja) カルバ環状ホスファチジン酸誘導体
WO2003051848A3 (en) Imidazolidineacetic acid derivatives
KR970074776A (ko) 치환된 2-나프토일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
EP0098609A2 (en) Novel cephalosporin compounds
López-Torres et al. Rhenium complexes with triazine derivatives formed from semicarbazones and thiosemicarbazones
DE69902782D1 (de) Substitutierte fünfgliedrige heterocyclische verbindungen, diese enthaltende fungizide zubereitungen und verfahren zur herstellung davon